Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06650833 in severe COVID-19 with ARDS
NCT04575610Phase 2Terminated
- Sponsor
- Yale University
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zimlovisertib in coronavirus disease 2019 (COVID-19), sponsored by Yale University. Started Nov 2020; status: terminated.
02
Drugs
zimlovisertib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04575610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04575610.